Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active...
Reexamination Certificate
2006-07-01
2011-10-04
Landsman, Robert (Department: 1647)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
C424S426000, C514S017200, C525S054100
Reexamination Certificate
active
08029774
ABSTRACT:
A composition includes at least one biologically active agent covalently attached to a first polymerizing molecule that is adapted to undergo a free radical polymerization. The first polymerizing molecule retains the ability to undergo free radical polymerization after attachment of the bioactive agent thereto. The first polymerizing molecule is preferably biocompatible. The polymerizing molecule can, for example. be dihydroxyphenyl-L-alanine (DOPA) or tyrosine. The composition can also include a second component synthesized by reacting at least one core molecule having a plurality of reactive hydrogen groups with at least one multi-isocyanate functional molecule to create a conjugate including terminal isocyanate groups. The conjugate molecule is reacted with a second polymerizing molecule that is adapted to undergo a free radical polymerization. The second polymerizing molecule includes a reactive hydrogen to react with the isocyanate groups of the conjugate. The second polymerizing molecule retains the ability to undergo the free radical polymerization after reaction with the conjugate. In several embodiments, the first polymerizing molecule and the second polymerizing molecule are the same and dihydroxyphenyl-L-alanine (DOPA) or tyrosine.
REFERENCES:
patent: 3800792 (1974-04-01), McKnight et al.
patent: 5643783 (1997-07-01), Olsen et al.
patent: 2004/0265951 (2004-12-01), Messersmith
patent: 2008/0144176 (2008-06-01), Sugimura et al.
patent: 0367362 (1990-05-01), None
patent: W09912975 (1999-03-01), None
patent: W02004029137 (2004-04-01), None
patent: W02005002597 (2005-01-01), None
patent: W02005118011 (2005-12-01), None
patent: W02007002318 (2007-01-01), None
patent: W02007005792 (2007-01-01), None
Lee BP. et al. Biomacromolecules 3:1038-1047, 2002.
Zhang JY, et al. Biomaterials 21(12):1247-1258, 2000.
Thomas S, McCubbin, P. “A comparison of the antimicrobial effects of four silver-containing dressings on three organisms”, J Wound Care, 2003;12(3)101-107.
Holt KB,Bard AJ, “Interaction of silver(I) ions with the respiratory chain ofEscherichia coli: an electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+”, Biochemistry 2005;44 (39):13214-13223.
Bragg PD, Rainnie DJ., “The effect of silver ions on the respiratory chain ofE. coli.” Can J Microbiol 1974;20 (6):883-889.
Darouiche RO., “Anti-infective efficacy of silver-coated medical prostheses.” Clinical Infectious Diseases, 1999;29 (6):1371-1377.
Chaw KC, Manimaran M, Tay Feh., “Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in staphylococcus epidermidis biofilms”. Antimicrobial Agents Chemotherapy 2005;49(12):4853-4859.
Otani Y, Tabata Y, Ikada Y., “Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid) and carbodiimide”. Biomaterials 1998;19(22):2091-2098.
Badylak Stephen F.
Beckman Eric J.
Freytes Donald
Wells Alan H.
Zhang Jianying
Bartony & Associates LLC
Landsman Robert
University of Pittsburgh
LandOfFree
Wound healing polymeric networks does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wound healing polymeric networks, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wound healing polymeric networks will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280402